Implementation of the FDA Food Safety Modernization Act Provision Requiring FDA To Establish Pilot Projects and Submit a Report to Congress for the Improvement of Tracking and Tracing of Food; Request for Comments and for Information, 14309-14311 [2013-04997]
Download as PDF
Federal Register / Vol. 78, No. 43 / Tuesday, March 5, 2013 / Notices
residues from veterinary antimicrobial
drugs with regard to effects on the
human intestinal flora. The objectives of
this guidance are to: (1) Outline the
steps in determining the need for
establishing a microbiological
acceptable daily intake (ADI); (2)
recommend test systems and methods
for determining no-observable adverse
effect concentrations (NOAECs) and noobservable adverse effect levels
(NOAELs) for the endpoints of health
concern; and (3) recommend a
procedure to derive a microbiological
ADI. It is recognized that different tests
may be useful. The experience gained
with the recommended tests may result
in future modifications to this guidance
and its recommendations.
III. Significance of Guidance
This guidance, developed under the
VICH process, has been revised to
conform to FDA’s good guidance
practices regulation (21 CFR 10.115).
For example, the document has been
designated ‘‘guidance’’ rather than
‘‘guideline.’’ In addition, guidance
documents must not include mandatory
language such as ‘‘shall,’’ ‘‘must,’’
‘‘require,’’ or ‘‘requirement,’’ unless
FDA is using these words to describe a
statutory or regulatory requirement.
This guidance represents the Agency’s
current thinking on this topic. It does
not create or confer any rights for or on
any person and does not operate to bind
FDA or the public. An alternative
approach may be used if such approach
satisfies the requirements of the
applicable statutes and regulations.
IV. Paperwork Reduction Act of 1995
This guidance refers to previously
approved collections of information
found in FDA regulations. These
collections of information are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501–
3520). The collections of information in
this guidance have been approved under
OMB control number 0910–0032.
emcdonald on DSK67QTVN1PROD with NOTICES
V. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) either electronic or written
comments regarding this document. It is
only necessary to send one set of
comments. Identify comments with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
VerDate Mar<15>2010
15:14 Mar 04, 2013
Jkt 229001
VI. Electronic Access
Persons with access to the Internet
may obtain the guidance at either https://
www.fda.gov/AnimalVeterinary/
GuidanceComplianceEnforcement/
GuidanceforIndustry/default.htm or
https://www.regulations.gov.
Dated: February 27, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013–05016 Filed 3–4–13; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–1153]
Implementation of the FDA Food
Safety Modernization Act Provision
Requiring FDA To Establish Pilot
Projects and Submit a Report to
Congress for the Improvement of
Tracking and Tracing of Food; Request
for Comments and for Information
AGENCY:
Food and Drug Administration,
HHS.
Notice; request for comments
and information.
ACTION:
SUMMARY: In September 2011, the Food
and Drug Administration (FDA or the
Agency) asked the Institute of Food
Technologists (IFT) to execute product
tracing pilot projects as described in the
FDA Food Safety Modernization Act
(FSMA). FDA recently released a report
from IFT on these pilot projects, entitled
‘‘Pilot Projects for Improving Product
Tracing along the Food Supply System.’’
FDA is announcing the opening of a
docket to provide stakeholders and
other interested parties an opportunity
to submit comments and information
that will help the Agency as it forms its
own recommendations, to be contained
in the Agency’s report to Congress, and
as it implements the FSMA provisions
relating to the tracking and tracing of
food.
DATES: Submit electronic or written
comments and information by April 4,
2013.
ADDRESSES: You may submit comments
and information, identified by Docket
No.FDA–2012–N–2012–N–1153, by any
of the following methods:
Electronic Submissions
Submit electronic comments and
information in the following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments
and information.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
14309
Written Submissions
Submit written submissions in the
following way:
• Mail/Hand delivery/Courier (for
paper, disk, or CD–ROM submissions):
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852.
Instructions: All submissions received
must include the Agency name and
Docket No. FDA–2012–N–1153 for this
notice. All comments and information
received may be posted without change
to https://www.regulations.gov, including
any personal information provided. For
additional information on submitting
comments and information, see the
‘‘Comments’’ heading of the
SUPPLEMENTARY INFORMATION section of
this document.
Docket: For access to the docket to
read background documents or
comments and information received, go
to https://www.regulations.gov and insert
the docket number(s), found in brackets
in the heading of this document, into
the ‘‘Search’’ box and follow the
prompts and/or go to the Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Sherri A. McGarry, Office of Foods,
Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 1, Rm.
1212, Silver Spring, MD 20903, 301–
796–3851.
SUPPLEMENTARY INFORMATION:
I. Background
A. FSMA Provisions Regarding
Enhanced Tracking and Tracing of Food
and Recordkeeping
On January 4, 2011, the President
signed FSMA (Pub. L. 111–353) into
law. Section 204 of FSMA, 21 U.S.C.
2223, relates to enhanced tracking and
tracing of food and recordkeeping. As
part of this provision, FDA must, among
other things, complete the following:
1. Establish pilot projects in
coordination with the food industry to
explore and evaluate methods for rapid
and effective tracking and tracing of
foods. FDA is required to submit a
report to Congress on the findings of the
pilot projects together with FDA’s
recommendations for improving
tracking and tracing of food;
2. Assess the costs and benefits
associated with the adoption and use of
several product tracing technologies and
the feasibility of such technologies for
different sectors of the food industry
(including small businesses);
3. To the extent practicable in
assessing the costs, benefits, and
E:\FR\FM\05MRN1.SGM
05MRN1
14310
Federal Register / Vol. 78, No. 43 / Tuesday, March 5, 2013 / Notices
emcdonald on DSK67QTVN1PROD with NOTICES
feasibility of several product tracing
technologies, evaluate domestic and
international product tracing practices;
consider international efforts and
compatibility with global tracing
systems, as appropriate; and consult
with a diverse and broad range of
experts and stakeholders;
4. Establish within FDA, as
appropriate, a product tracing system to
receive information that improves the
capacity of the Secretary to effectively
and rapidly track and trace food;
5. Publish a notice of proposed
rulemaking to establish additional
recordkeeping requirements for high
risk foods;
6. Designate high-risk foods for which
the additional recordkeeping
requirements are appropriate and
necessary to protect the public health.
The list of high-risk foods is to be
published on FDA’s Internet Web site
when the Agency issues the final rule
establishing additional recordkeeping
requirements for high-risk foods; and
7. Issue a small entity compliance
guide within 6 months after the final
rule is issued.
B. FSMA Provisions Directing FDA To
Establish Pilot Projects To Explore and
Evaluate Methods for Rapid and
Effective Tracking and Tracing of Foods
Under section 204(a) of FSMA, in
September 2011, FDA established pilot
projects in coordination with the food
industry to explore and evaluate
methods for rapid and effective tracking
and tracing of foods. These product
tracing pilots were executed through an
existing contract with the IFT. IFT was
required to:
1. Conduct two food product tracing
pilot projects—one in coordination with
the processed food sector and one in
coordination with the produce sectors—
working in consultation with the U.S.
Department of Agriculture, State public
health agencies, and nongovernmental
organizations that represent the interests
of consumers;
2. Conduct the pilot projects to reflect
the diversity of the food supply and
consider/address confounding factors,
such as commingling and
transshipment;
3. Include different types of FDAregulated foods that were the subject of
significant outbreaks between 2005 and
2010;
4. Use the selected foods to develop
and demonstrate methods for rapid and
effective tracking and tracing of foods
that are practical for facilities of varying
sizes, including small businesses;
5. Use the selected foods to
demonstrate appropriate technologies
that enhance the tracking and tracing of
VerDate Mar<15>2010
15:14 Mar 04, 2013
Jkt 229001
foods along the supply chain from
source to points of service;
6. Demonstrate the tracking and
tracing of: (a) A selected processed food
and its key ingredients (minimum of
two ingredients) and (b) a selected fruit
and/or vegetable along the supply chain;
7. Assess the costs and benefits of the
methods for rapid and effective tracking
and tracing of the selected foods and
key ingredients; and
8. Determine the feasibility of product
tracing technologies for different sectors
of the food industry, including small
businesses.
FDA released the report containing
the findings of the pilot projects,
entitled ‘‘Pilot Projects for Improving
Product Tracing along the Food Supply
System’’ in March 2013. The report is
available on FDA’s Product Tracing Web
page at https://www.fda.gov/Food/
FoodSafety/FSMA/ucm270851.htm.
This extensive report is being reviewed
by FDA. After careful review of this
report and information previously
gathered, FDA will submit its report to
Congress containing FDA
recommendations for improving
product tracing. This docket is being
opened in order to request comments on
the pilot project report’s findings and
recommendations to help inform FDA
in preparing its recommendations in the
Agency’s report to Congress.
C. Request for Comments and
Information
In addition to providing the findings
of the pilot projects, the report contains
IFT’s recommendations for FDA on
improving tracking and tracing of food.
FDA released this report to make it
available for stakeholders and to solicit
input that may be helpful as FDA forms
its own recommendations, to be
contained in the Agency’s report to
Congress, and as FDA implements other
FSMA requirements related to product
tracing. FDA invites comment on the
findings and recommendations
contained in the IFT report and the
submission of information relevant to
improving product tracing. In addition,
FDA would like specific comment on
the following:
1. The report contains specific
recommendations regarding key data
elements (KDEs) and critical tracking
events (CTEs). How might this work for
your industry segment? What would
you keep the same or change in Table
2 in the Executive Brief of the report?
Please include an explanation of why
you would keep the same or change.
2. The report recommends that all
foods be covered, not just high-risk
foods. The rulemaking requirement in
section 204(d) of FSMA only refers to
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
high-risk foods. Should FDA pursue
implementation of some or all of the
report’s recommendations with respect
to all foods, not just high-risk foods? If
so, what routes might the Agency use?
3. The report recommends that each
member of the food supply chain should
be required to develop, document, and
exercise a product tracing plan. FDA is
aware that industry often conducts and
documents recall exercises, which are
essentially traceforward exercises. Is it
feasible to add a traceback to existing
procedures and exercises? Should FDA
include this IFT recommendation as one
of its recommendations in the Agency’s
report to Congress? Please explain why
the FDA should or should not include.
4. What additional information and
data sources could be used to determine
cost and benefits associated with
implementing IFT’s recommendations
for KDEs and CTEs?
5. How might FDA more clearly and
consistently articulate the information it
needs to conduct product tracing
investigations? Would posting
information on FDA’s Web site on how
FDA typically conducts a traceback or
traceforward be helpful?
6. The report recommends that FDA
develop standardized electronic
mechanisms for the reporting and
acquiring of CTEs and KDEs during
product tracing investigations. How
would this work for your industry
segment? How might it be achieved
most expeditiously?
7. Is there anything else FDA should
consider in preparing its
recommendations for improving
product tracing in the Agency’s report to
Congress?
II. Comments
Interested persons may submit either
electronic comments regarding this
document to https://www.regulations.gov
or written comments to the Division of
Dockets Management (see ADDRESSES). It
is only necessary to send one set of
comments. Identify comments with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday, and
will be posted to the docket at https://
www.regulations.gov.
III. References
The following reference has been
placed on display in the Division of
Dockets Management (see ADDRESSES)
and may be seen by interested persons
between 9 a.m. and 4 p.m., Monday
through Friday, and is available
electronically at https://
www.regulations.gov.
E:\FR\FM\05MRN1.SGM
05MRN1
Federal Register / Vol. 78, No. 43 / Tuesday, March 5, 2013 / Notices
1. McEntire, Jennifer and Bhatt, Tejas, ‘‘Pilot
Projects for Improving Product Tracing
Along the Food Supply System—Final
Report,’’ Institute of Food Technologists,
August 2012.
Dated: February 27, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013–04997 Filed 3–4–13; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
emcdonald on DSK67QTVN1PROD with NOTICES
Advisory Commission on Childhood
Vaccines; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Commission on
Childhood Vaccines (ACCV).
Date and Time: March 07, 2013, 10:00
a.m. to 4:00 p.m. EDT.
Place: Audio Conference Call.
The ACCV will meet on Thursday,
March 7, from 10:00 a.m. to 4:00 p.m.
(EDT). The public can join the meeting
via audio conference call by dialing 1–
800–369–3104 on March 7 and
providing the following information:
Leader’s Name: Dr. Vito Caserta.
Password: ACCV.
Agenda: The agenda items for the
March meeting will include, but are not
limited to: Updates from the Division of
Vaccine Injury Compensation (DVIC),
Department of Justice (DOJ), National
Vaccine Program Office (NVPO),
Immunization Safety Office (Centers for
Disease Control and Prevention),
National Institute of Allergy and
Infectious Diseases (National Institutes
of Health) and Center for Biologics,
Evaluation and Research (Food and
Drug Administration). A draft agenda
and additional meeting materials will be
posted on the ACCV Web site (https://
www.hrsa.gov/vaccinecompensation/
accv.htm) prior to the meeting. Agenda
items are subject to change as priorities
dictate.
Public Comment: Persons interested
in providing an oral presentation should
submit a written request, along with a
copy of their presentation to: Annie
Herzog, DVIC, Healthcare Systems
Bureau (HSB), Health Resources and
Services Administration (HRSA), Room
11C–26, 5600 Fishers Lane, Rockville,
MD 20857 or email: aherzog@hrsa.gov.
Requests should contain the name,
address, telephone number, email
address, and any business or
VerDate Mar<15>2010
15:14 Mar 04, 2013
Jkt 229001
professional affiliation of the person
desiring to make an oral presentation.
Groups having similar interests are
requested to combine their comments
and present them through a single
representative. The allocation of time
may be adjusted to accommodate the
level of expressed interest. DVIC will
notify each presenter by email, mail or
telephone of their assigned presentation
time. Persons who do not file an
advance request for a presentation, but
desire to make an oral statement, may
announce it at the time of the public
comment period. Public participation
and ability to comment will be limited
to space and time as it permits.
For Further Information Contact:
Anyone requiring information regarding
the ACCV should contact Annie Herzog,
DVIC, HSB, HRSA, Room 11C–26, 5600
Fishers Lane, Rockville, MD 20857;
telephone (301) 443–6593 or email:
aherzog@hrsa.gov.
Dated: February 26, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–04953 Filed 3–4–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Statement of Organization, Functions
and Delegations of Authority
This notice amends Part R of the
Statement of Organization, Functions
and Delegations of Authority of the
Department of Health and Human
Services (HHS), Health Resources and
Services Administration (HRSA) (60 FR
56605, as amended November 6, 1995;
as last amended at 78 FR 956–957, dated
January 7, 2013).
This notice reflects organizational
changes to the Health Resources and
Services Administration. This notice
updates the functional statement for the
Office of Federal Assistance
Management (RJ). Specifically, this
notice: (1) Moves the grant officer and
loan officer function from the Office of
the Associate Administrator (RJ) to the
Division of Grants Management
Operations (RJ3); and (2) moves the
electronic grant management system
function from the Division of Grants
Management Operations (RJ3) to the
Office of the Associate Administrator
(RJ).
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
14311
Chapter RJ—Office of Federal
Assistance Management
Section RJ–20, Functions
(1) Delete the functional statement for
the Office of the Associate
Administrator (RJ) and the functional
statement for the Division of Grants
Management Operations (RJ3), and
replace in their entirety.
Office of Federal Assistance
Management (RJ)
Provides national leadership in the
administration and assurance of the
financial integrity of HRSA’s programs
and provides oversight over all HRSA
activities to ensure that HRSA’s
resources are being properly used and
protected. Provides leadership,
direction, and coordination to all phases
of grants policy, administration, and
independent review of competitive
grant applications. Specifically: (1)
Serves as the Administrator’s principal
source for grants policy and financial
integrity of HRSA programs; (2)
exercises oversight over the Agency’s
business processes related to assistance
programs; (3) facilitates, plans, directs,
and coordinates the administration of
HRSA grant policies and operations; (4)
directs and carries out the independent
review of grant applications for all of
HRSA’s programs; (5) exercises the sole
responsibility within HRSA for all
aspects of grant and cooperative
agreement receipt, award, and postaward processes: and (6) provides
oversight of the management and
maintenance of, and enhancements to,
the electronic grant management system
that enables staff to perform their dayto-day work.
Division of Grants Management
Operations (RJ3)
(1) Plans, directs and carries out the
grants officer functions for all of HRSA’s
grant programs as well as awarding
official functions for various
scholarship, loan, and loan repayment
assistance programs; (2) participates in
the planning, development, and
implementation of policies and
procedures for grants and cooperative
agreements; (3) provides assistance and
technical consultation to program
offices and grantees in the application of
laws, regulations, policies, and
guidelines relative to the Agency’s grant
and cooperative agreement programs; (4)
develops standard operating procedures,
methods, and materials for the
administration of the Agency’s grants
programs; (5) establishes standards and
guides for grants management
operations; (6) reviews grantee financial
status reports and prepares reports and
E:\FR\FM\05MRN1.SGM
05MRN1
Agencies
[Federal Register Volume 78, Number 43 (Tuesday, March 5, 2013)]
[Notices]
[Pages 14309-14311]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-04997]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-1153]
Implementation of the FDA Food Safety Modernization Act Provision
Requiring FDA To Establish Pilot Projects and Submit a Report to
Congress for the Improvement of Tracking and Tracing of Food; Request
for Comments and for Information
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; request for comments and information.
-----------------------------------------------------------------------
SUMMARY: In September 2011, the Food and Drug Administration (FDA or
the Agency) asked the Institute of Food Technologists (IFT) to execute
product tracing pilot projects as described in the FDA Food Safety
Modernization Act (FSMA). FDA recently released a report from IFT on
these pilot projects, entitled ``Pilot Projects for Improving Product
Tracing along the Food Supply System.'' FDA is announcing the opening
of a docket to provide stakeholders and other interested parties an
opportunity to submit comments and information that will help the
Agency as it forms its own recommendations, to be contained in the
Agency's report to Congress, and as it implements the FSMA provisions
relating to the tracking and tracing of food.
DATES: Submit electronic or written comments and information by April
4, 2013.
ADDRESSES: You may submit comments and information, identified by
Docket No.FDA-2012-N-2012-N-1153, by any of the following methods:
Electronic Submissions
Submit electronic comments and information in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments and information.
Written Submissions
Submit written submissions in the following way:
Mail/Hand delivery/Courier (for paper, disk, or CD-ROM
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
Instructions: All submissions received must include the Agency name
and Docket No. FDA-2012-N-1153 for this notice. All comments and
information received may be posted without change to https://www.regulations.gov, including any personal information provided. For
additional information on submitting comments and information, see the
``Comments'' heading of the SUPPLEMENTARY INFORMATION section of this
document.
Docket: For access to the docket to read background documents or
comments and information received, go to https://www.regulations.gov and
insert the docket number(s), found in brackets in the heading of this
document, into the ``Search'' box and follow the prompts and/or go to
the Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Sherri A. McGarry, Office of Foods,
Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 1, Rm.
1212, Silver Spring, MD 20903, 301-796-3851.
SUPPLEMENTARY INFORMATION:
I. Background
A. FSMA Provisions Regarding Enhanced Tracking and Tracing of Food and
Recordkeeping
On January 4, 2011, the President signed FSMA (Pub. L. 111-353)
into law. Section 204 of FSMA, 21 U.S.C. 2223, relates to enhanced
tracking and tracing of food and recordkeeping. As part of this
provision, FDA must, among other things, complete the following:
1. Establish pilot projects in coordination with the food industry
to explore and evaluate methods for rapid and effective tracking and
tracing of foods. FDA is required to submit a report to Congress on the
findings of the pilot projects together with FDA's recommendations for
improving tracking and tracing of food;
2. Assess the costs and benefits associated with the adoption and
use of several product tracing technologies and the feasibility of such
technologies for different sectors of the food industry (including
small businesses);
3. To the extent practicable in assessing the costs, benefits, and
[[Page 14310]]
feasibility of several product tracing technologies, evaluate domestic
and international product tracing practices; consider international
efforts and compatibility with global tracing systems, as appropriate;
and consult with a diverse and broad range of experts and stakeholders;
4. Establish within FDA, as appropriate, a product tracing system
to receive information that improves the capacity of the Secretary to
effectively and rapidly track and trace food;
5. Publish a notice of proposed rulemaking to establish additional
recordkeeping requirements for high risk foods;
6. Designate high-risk foods for which the additional recordkeeping
requirements are appropriate and necessary to protect the public
health. The list of high-risk foods is to be published on FDA's
Internet Web site when the Agency issues the final rule establishing
additional recordkeeping requirements for high-risk foods; and
7. Issue a small entity compliance guide within 6 months after the
final rule is issued.
B. FSMA Provisions Directing FDA To Establish Pilot Projects To Explore
and Evaluate Methods for Rapid and Effective Tracking and Tracing of
Foods
Under section 204(a) of FSMA, in September 2011, FDA established
pilot projects in coordination with the food industry to explore and
evaluate methods for rapid and effective tracking and tracing of foods.
These product tracing pilots were executed through an existing contract
with the IFT. IFT was required to:
1. Conduct two food product tracing pilot projects--one in
coordination with the processed food sector and one in coordination
with the produce sectors--working in consultation with the U.S.
Department of Agriculture, State public health agencies, and
nongovernmental organizations that represent the interests of
consumers;
2. Conduct the pilot projects to reflect the diversity of the food
supply and consider/address confounding factors, such as commingling
and transshipment;
3. Include different types of FDA-regulated foods that were the
subject of significant outbreaks between 2005 and 2010;
4. Use the selected foods to develop and demonstrate methods for
rapid and effective tracking and tracing of foods that are practical
for facilities of varying sizes, including small businesses;
5. Use the selected foods to demonstrate appropriate technologies
that enhance the tracking and tracing of foods along the supply chain
from source to points of service;
6. Demonstrate the tracking and tracing of: (a) A selected
processed food and its key ingredients (minimum of two ingredients) and
(b) a selected fruit and/or vegetable along the supply chain;
7. Assess the costs and benefits of the methods for rapid and
effective tracking and tracing of the selected foods and key
ingredients; and
8. Determine the feasibility of product tracing technologies for
different sectors of the food industry, including small businesses.
FDA released the report containing the findings of the pilot
projects, entitled ``Pilot Projects for Improving Product Tracing along
the Food Supply System'' in March 2013. The report is available on
FDA's Product Tracing Web page at https://www.fda.gov/Food/FoodSafety/FSMA/ucm270851.htm. This extensive report is being reviewed by FDA.
After careful review of this report and information previously
gathered, FDA will submit its report to Congress containing FDA
recommendations for improving product tracing. This docket is being
opened in order to request comments on the pilot project report's
findings and recommendations to help inform FDA in preparing its
recommendations in the Agency's report to Congress.
C. Request for Comments and Information
In addition to providing the findings of the pilot projects, the
report contains IFT's recommendations for FDA on improving tracking and
tracing of food. FDA released this report to make it available for
stakeholders and to solicit input that may be helpful as FDA forms its
own recommendations, to be contained in the Agency's report to
Congress, and as FDA implements other FSMA requirements related to
product tracing. FDA invites comment on the findings and
recommendations contained in the IFT report and the submission of
information relevant to improving product tracing. In addition, FDA
would like specific comment on the following:
1. The report contains specific recommendations regarding key data
elements (KDEs) and critical tracking events (CTEs). How might this
work for your industry segment? What would you keep the same or change
in Table 2 in the Executive Brief of the report? Please include an
explanation of why you would keep the same or change.
2. The report recommends that all foods be covered, not just high-
risk foods. The rulemaking requirement in section 204(d) of FSMA only
refers to high-risk foods. Should FDA pursue implementation of some or
all of the report's recommendations with respect to all foods, not just
high-risk foods? If so, what routes might the Agency use?
3. The report recommends that each member of the food supply chain
should be required to develop, document, and exercise a product tracing
plan. FDA is aware that industry often conducts and documents recall
exercises, which are essentially traceforward exercises. Is it feasible
to add a traceback to existing procedures and exercises? Should FDA
include this IFT recommendation as one of its recommendations in the
Agency's report to Congress? Please explain why the FDA should or
should not include.
4. What additional information and data sources could be used to
determine cost and benefits associated with implementing IFT's
recommendations for KDEs and CTEs?
5. How might FDA more clearly and consistently articulate the
information it needs to conduct product tracing investigations? Would
posting information on FDA's Web site on how FDA typically conducts a
traceback or traceforward be helpful?
6. The report recommends that FDA develop standardized electronic
mechanisms for the reporting and acquiring of CTEs and KDEs during
product tracing investigations. How would this work for your industry
segment? How might it be achieved most expeditiously?
7. Is there anything else FDA should consider in preparing its
recommendations for improving product tracing in the Agency's report to
Congress?
II. Comments
Interested persons may submit either electronic comments regarding
this document to https://www.regulations.gov or written comments to the
Division of Dockets Management (see ADDRESSES). It is only necessary to
send one set of comments. Identify comments with the docket number
found in brackets in the heading of this document. Received comments
may be seen in the Division of Dockets Management between 9 a.m. and 4
p.m., Monday through Friday, and will be posted to the docket at https://www.regulations.gov.
III. References
The following reference has been placed on display in the Division
of Dockets Management (see ADDRESSES) and may be seen by interested
persons between 9 a.m. and 4 p.m., Monday through Friday, and is
available electronically at https://www.regulations.gov.
[[Page 14311]]
1. McEntire, Jennifer and Bhatt, Tejas, ``Pilot Projects for
Improving Product Tracing Along the Food Supply System--Final
Report,'' Institute of Food Technologists, August 2012.
Dated: February 27, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-04997 Filed 3-4-13; 8:45 am]
BILLING CODE 4160-01-P